MALLORY QUINCEY: Open Payments
NPI 1407374739 · CENTRE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 14 payments from 9 companies in 2025. Trend: 2023 $1,687 · 2024 $882 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $126 |
| Boston Scientific Corporation | 1 | $123 |
| Amgen Inc. | 1 | $121 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $57 |
| PFIZER INC. | 2 | $44 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $40 |
| ABBVIE INC. | 1 | $36 |
| Ossur Americas, Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: LEQVIO, WATCHMAN FLX, JARDIANCE, ELIQUIS, LifeVest, UBRELVY, VERQUVO.
Industry payments across AL — which companies pay providers there.
